Jones Day advised Labcorp on the deal. Labcorp (NYSE: LH), a leading global life sciences company, announced its consideration of whether to pursue a spin-off of its...
Labcorp’s Spin Off of Clinical Development Business
Labcorp’s Strategic Laboratory Agreement With Ascension
Hogan Lovells advised Labcorp on the deal while Jones Day represented Ascension. Labcorp, a leading global life sciences company, signed an agreement to create a comprehensive...
LabCorp’s US$1 Billion Senior Notes Offering
Hogan Lovells represented LabCorp on the deal. The offering consisted of US$500 million aggregate principal amount of 1.550% Senior Notes due 2026 and $500 million aggregate...
Labcorp on US$150 Million Acquisition Of Myriad Genetics’ Vectra Testing Business
Hogan Lovells advised Labcorp on the deal. Labcorp acquired select operating assets and intellectual property from Myriad Genetics’ autoimmune business unit, including the Vectra® rheumatoid arthritis assay,...